Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis
Webinar/Online
Monday, June 16, 2025 at 12:00pm ET - 1:00pm ET
Add this event to your calendar
Posted by Nurse Practitioner Events
Info
Topic
Join us for a series of three live, virtual 60-minute CME/CE-certified webinars focused on clinical decision-making with IL-13 inhibitors in moderate to severe atopic dermatitis. Through interactive, case-based discussions, expert faculty will share practical insights and real-world strategies. Participants will also have the opportunity to pose questions directly to the panel and engage in thoughtful dialogue
Credits Offered
This event offers
1.0 contact hour
to attendees.
Accreditation Info:
ANCC.
Additional Information
Agenda:
- Case 1: Mapping IL-13 to the Clinical Manifestations of Atopic Dermatitis
- Case 2: IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
- Case 3: Practical Considerations for IL-13 Inhibitors: Patient Candidacy and Treatment Advancement Strategies
- Final Q&A, Recap
Goal Statement
The goal of this educational activity is to improve learners’ knowledge, competence, and performance managing advanced therapy for patients with moderate to severe atopic dermatitis.
Target Audience
This education is intended for dermatologists, allergist/immunologists, and nurse practitioners (NPs) and physician associates (PAs) practicing in dermatology and allergy who manage patients with moderate to severe atopic dermatitis.
Learning Objectives
Upon completion of this activity, participants should be able to:
-
Understand the pathophysiologic contributions of IL-13 in promoting the clinical manifestations of moderate to severe AD
-
Evaluate available evidence and current guidelines to differentiate advanced therapies targeting IL-13 in moderate to severe AD
- Assess patient candidacy for advanced biologic therapies targeting IL-13 in moderate to severe AD
This program is independent and is not part of the official AAD Annual Meeting, as planned by its Scientific Assembly Committee.
This program does not qualify for Continuing Medical Education (CME) Credit.
Speakers
Professor of Clinical Dermatology
Weill Cornell Medicine
New York, New York
Assistant Dean of Student Affairs
Associate Professor
University of Arizona College of Medicine
Tucson, Arizona
Dr. Joseph W. Burnett Professor and Chair
Department of Dermatology
University of Maryland School of Medicine
Baltimore, Maryland